Hou Z-J, Luo X, Zhang W, Peng F, Cui B, Wu S-J, Zheng F-M, Xu J, Xu L-Z, Long Z-J, et al. Flubendazole, FDA-approved anthelmintic, targets breast cancer stem-like cells. Oncotarget. 2015;6(8):6326-6340. Google ScholarPubMedLog in or register to post comments